This level of detail allows you to truly understand how your body is changing on GLP-1 therapy
Truemed itself does not make eligibility determinations
Reduced appetite and lower calorie intake can leave people feeling sluggish, especially in the early phases of treatment
Boost your Performance and Burn Fat for Sports

Key points: GLP-1s (glucagon-like peptide-1 receptor agonists) support type 2 diabetes by reducing appetite and supporting weight loss alongside their effects on the pancreas GLP-1-assisted programmes lead to a clinically significant weight loss of 10% or more, which can significantly reduce complications associated with obesity Combining semaglutide with lifestyle interventions leads to significantly more weight loss than lifestyle interventions alone, with 87% of participants losing more than 10% of their body weight Semaglutide is more effective at supporting weight loss than liraglutide Tirzepatide is more effective than semaglutide at reducing weight, with all three doses of tirzepatide leading to more significant weight loss than 1mg of semaglutide The higher doses of tirzepatide (10mg and 15mg) might reduce weight by 5.15kg more than 2mg of semaglutide, while there appears to be no difference between 5mg of tirzepatide and 2mg of semaglutide 3) Side effects and safety All medications have possible side effects, particularly if you live with other health conditions

Wang Z, Ge Q, Wu Y, Zhang J, Gu Q, Han J (2020) Impairment of long-term memory by a short-term high-fat Diet via hippocampal oxidative stress and alterations in synaptic plasticity